OPKO Health, Inc. (LON:0KCS)

Market Cap	703.33M -13.3%
Revenue (ttm)	477.66M -9.7%
Net Income	-134.20M
EPS	-0.18
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	504
Average Volume	5,327
Open	1.240
Previous Close	1.247
Day's Range	1.231 - 1.250
52-Week Range	1.130 - 2.020
Beta	1.39
RSI	40.52
Earnings Date	Feb 27, 2026

About OPKO Health

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, ...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 2007
• Employees: 2,997
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KCS

Financial Performance

In 2024, OPKO Health's revenue was $713.14 million, a decrease of -17.41% compared to the previous year's $863.50 million. Losses were -$53.22 million, -71.82% less than in 2023.

Financial numbers in USD